NatWest Group plc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 181 filers reported holding NEKTAR THERAPEUTICS in Q4 2015. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
NatWest Group plc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2015$492,000
-0.2%
44,8460.0%0.01%
+83.3%
Q1 2015$493,000
-32.4%
44,846
-4.6%
0.01%0.0%
Q4 2014$729,000
-37.7%
47,016
-51.5%
0.01%
-40.0%
Q3 2014$1,171,000
-3.5%
96,978
+2.5%
0.01%
-80.4%
Q2 2014$1,213,000
+17.5%
94,653
+11.1%
0.05%
+10.9%
Q1 2014$1,032,000
-7.8%
85,164
-13.6%
0.05%
+64.3%
Q4 2013$1,119,000
+35.8%
98,598
+25.0%
0.03%
+16.7%
Q3 2013$824,000
-15.0%
78,883
-5.9%
0.02%
+71.4%
Q2 2013$969,00083,8620.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2015
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
Virtus ETF Advisers LLC 72,018$230,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders